165 related articles for article (PubMed ID: 34727402)
1. Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin.
Barbanente A; Galliani A; Iacobazzi RM; Lasorsa A; Nardella MI; Pennetta A; Margiotta N; Arnesano F
ChemMedChem; 2022 Jan; 17(1):e202100593. PubMed ID: 34727402
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
[TBL] [Abstract][Full Text] [Related]
3. Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy.
Curci A; Gandin V; Marzano C; Hoeschele JD; Natile G; Margiotta N
Inorg Chem; 2017 Jul; 56(13):7482-7493. PubMed ID: 28636387
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells.
Maji M; Bhattacharya I; Acharya S; Chakraborty MP; Gupta A; Mukherjee A
Inorg Chem; 2021 Apr; 60(7):4342-4346. PubMed ID: 33711231
[TBL] [Abstract][Full Text] [Related]
5. Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA.
Kasparkova J; Kostrhunova H; Novohradsky V; Pracharova J; Curci A; Margiotta N; Natile G; Brabec V
Dalton Trans; 2017 Oct; 46(41):14139-14148. PubMed ID: 28972623
[TBL] [Abstract][Full Text] [Related]
6. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
[TBL] [Abstract][Full Text] [Related]
7. Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.
Scaffidi-Domianello YY; Legin AA; Jakupec MA; Roller A; Kukushkin VY; Galanski MS; Keppler BK
Inorg Chem; 2012 Jul; 51(13):7153-63. PubMed ID: 22691006
[TBL] [Abstract][Full Text] [Related]
8. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
Yu H; Gou S; Wang Z; Chen F; Fang L
Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma.
Igarashi K; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Odani A; Tsuchiya H
Anticancer Agents Med Chem; 2015; 15(3):390-9. PubMed ID: 25511510
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Activity Assessment and DNA Binding Properties of Two Binuclear Platinum (II) Complexes using Spectroscopic and Molecular Simulation Approaches.
Alavianmehr MM; Ashrafi A; Yousefi R; Haghighi MG; Abolmaali SS; Moosavi-Movahedi AA; Rad MNS
Anticancer Agents Med Chem; 2020; 20(17):2066-2073. PubMed ID: 32628598
[TBL] [Abstract][Full Text] [Related]
11. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
Lozada IB; Huang B; Stilgenbauer M; Beach T; Qiu Z; Zheng Y; Herbert DE
Dalton Trans; 2020 May; 49(20):6557-6560. PubMed ID: 32342084
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
13. Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance.
Hildebrandt J; Häfner N; Görls H; Kritsch D; Ferraro G; Dürst M; Runnebaum IB; Merlino A; Weigand W
Dalton Trans; 2016 Nov; 45(47):18876-18891. PubMed ID: 27897281
[TBL] [Abstract][Full Text] [Related]
14. New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells.
Hyeraci M; Scalcon V; Folda A; Labella L; Marchetti F; Samaritani S; Rigobello MP; Dalla Via L
ChemMedChem; 2021 Jun; 16(12):1956-1966. PubMed ID: 33751814
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands.
Navas F; Mendes F; Santos I; Navarro-Ranninger C; Cabrera S; Quiroga AG
Inorg Chem; 2017 Jun; 56(11):6175-6183. PubMed ID: 28488859
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery.
Berger G; Leclercqz H; Derenne A; Gelbcke M; Goormaghtigh E; Nève J; Mathieu V; Dufrasne F
Bioorg Med Chem; 2014 Jul; 22(13):3527-36. PubMed ID: 24818960
[TBL] [Abstract][Full Text] [Related]
17. Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand.
Martín Santos C; Cabrera S; Ríos-Luci C; Padrón JM; López Solera I; Quiroga AG; Medrano MA; Navarro-Ranninger C; Alemán J
Dalton Trans; 2013 Oct; 42(37):13343-8. PubMed ID: 23945635
[TBL] [Abstract][Full Text] [Related]
18. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
Howell SB; Safaei R; Larson CA; Sailor MJ
Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors.
Xu Z; Li C; Zhou Q; Deng Z; Tong Z; Tse MK; Zhu G
Inorg Chem; 2019 Dec; 58(23):16279-16291. PubMed ID: 31738050
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
